Tomoyuki Otani

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine

Kensuke Matsumoto, Tomoyuki Otani, T Une et al. · Infection and Immunity · 1983 · 62 citations · Full text

Antibiotic Adjuvant, Antimicrobial Chemotherapy, Antibiotic Resistance +17

Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections

Y Osada, Masao Mitsuyama, T Une et al. · Infection and Immunity · 1982 · 52 citations · Full text

Antibiotic Adjuvant, Immunology, Escherichia Coli +18

Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae

Ryo Okumura, Tsuyoshi Hirata, Yoshikuni Onodera et al. · Journal of Antimicrobial Chemotherapy · 2008 · 46 citations · Full text

The effects of ultraviolet irradiation of the skin on herpes simplex virus infection: alteration in immune function mediated by epidermal cells and in the course of infection

Tomoyuki Otani, Ryoichi Mori · Archives of Virology · 1987 · 43 citations

Cutaneous Biology, Immunology, Virology +9